carmustine

(redirected from BiCNU)
Also found in: Medical.

car·mus·tine

 (kär′mŭs-tēn′)
n.
An antineoplastic drug, C5H9Cl2N3O2, used to treat various malignancies, including Hodgkin and non-Hodgkin lymphomas, melanoma, multiple myeloma, and brain tumors.

[Probably car(bamoylation), transfer of a carbamoyl group to an amino acid (the drug's method of inhibiting certain enzymes) + mustine, an anticancer drug (must(ard) + -ine).]
References in periodicals archive ?
Most recently, Emcure-Heritage acquired the global rights to an exclusive oncology brand product, BiCNU (Carmustine for Injection), which serves as an anchor product in the company's growing oncology franchise.
Many Pfizer's Torisel of the kidney-cancer products treatment, Velcade, produced by a multiple-myeloma Ben Venue are treatment given to co-marketed by J&J cancer and Takeda patients along Pharmaceutical, and with new Bristol-Myers therapies and Squibb's BiCNU if supplies cancer drug.